Purchases and Sales Made in Q4 2022 in Cyclo Therapeutics, Inc. (CYTH)
This table provides information about the institutional ownership of Cyclo Therapeutics, Inc. (CYTH) during Q4 2022. The information is specifically focused on institutions that hold shares of Cyclo Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2023
Q4 2022
|
Armistice Capital, LLC
New York, NY |
BUY
|
- |
930KNew |
$884K - $1.98M
|
930K
$698K
|
|
Feb 13, 2023
Q4 2022
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
3.94K+ 8.15% |
$3.74K - $8.39K
|
52.3K
$39.2K
|
|
Feb 08, 2023
Q4 2022
|
Ubs Group Ag
|
BUY
|
- |
2.81KNew |
$2.67K - $5.99K
|
2.81K
$2.11K
|
|
Feb 06, 2023
Q4 2022
|
Princeton Global Asset Management LLC
|
BUY
|
- |
300New |
$285 - $639
|
300
$225
|
|
Feb 13, 2023
Q4 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
250+ 12.19% |
$238 - $533
|
2.3K
$1.73K
|
|
Feb 10, 2023
Q4 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
205+ 4.48% |
$195 - $437
|
4.79K
$3.59K
|
|
Feb 10, 2023
Q4 2022
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
117+ 0.05% |
$111 - $249
|
254K
$190K
|
|
Feb 10, 2023
Q4 2022
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
18New |
$17.1 - $38.3
|
18
$13.5
|
|
Jan 30, 2023
Q4 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|